GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stallergenes Greer PLC (GREY:STLLF) » Definitions » Cyclically Adjusted Price-to-FCF

Stallergenes Greer (Stallergenes Greer) Cyclically Adjusted Price-to-FCF : (As of May. 17, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Stallergenes Greer Cyclically Adjusted Price-to-FCF?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted Price-to-FCF for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Stallergenes Greer Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Stallergenes Greer's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stallergenes Greer Cyclically Adjusted Price-to-FCF Chart

Stallergenes Greer Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Stallergenes Greer Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Stallergenes Greer's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Stallergenes Greer's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stallergenes Greer's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stallergenes Greer's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Stallergenes Greer's Cyclically Adjusted Price-to-FCF falls into.



Stallergenes Greer Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Stallergenes Greer's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec18 is calculated as:

For example, Stallergenes Greer's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec18 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec18 (Change)*Current CPI (Dec18)
=2.403/107.1000*107.1000
=2.403

Current CPI (Dec18) = 107.1000.

Stallergenes Greer Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200912 2.082 88.900 2.508
201012 5.438 91.700 6.351
201112 1.964 95.000 2.214
201212 4.118 97.300 4.533
201312 2.913 99.200 3.145
201412 5.012 99.900 5.373
201512 -5.168 100.400 -5.513
201612 -4.179 102.200 -4.379
201712 -0.253 105.000 -0.258
201812 2.403 107.100 2.403

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Stallergenes Greer  (GREY:STLLF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Stallergenes Greer Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Stallergenes Greer's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Stallergenes Greer (Stallergenes Greer) Business Description

Traded in Other Exchanges
N/A
Address
40 Bernard Street, 3rd Floor, London, GBR, WC1N 1LE
Stallergenes Greer PLC is a pharmaceutical company. The company treats severe allergic rhinitis with allergen immunotherapy. Its portfolio comprises of Sublingual products, Subcutaneous products, Veterinary products and Other. The sublingual products are offered under the brand name Staloral and Oralair. The Subcutaneous products include Phostal, Alustal, Alyostal, Albey. The company also offers enzyme-linked immunosorbent assay components and prescription services. It provides skin testing devices enabling the identification of the allergen or allergens responsible for the allergy, sterile diluents and sterile empty vials, syringes, and other compendial products. The company operates in internationally and geographically generates maximum revenue from the United States.

Stallergenes Greer (Stallergenes Greer) Headlines

No Headlines